DYN
Price
$21.17
Change
+$0.37 (+1.78%)
Updated
Nov 26 closing price
Capitalization
3.03B
90 days until earnings call
Intraday BUY SELL Signals
LSTA
Price
$1.99
Change
-$0.06 (-2.93%)
Updated
Nov 28, 10:30 AM (EDT)
Capitalization
18.35M
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DYN vs LSTA

Header iconDYN vs LSTA Comparison
Open Charts DYN vs LSTABanner chart's image
Dyne Therapeutics
Price$21.17
Change+$0.37 (+1.78%)
Volume$3.08M
Capitalization3.03B
Lisata Therapeutics
Price$1.99
Change-$0.06 (-2.93%)
Volume$6.7K
Capitalization18.35M
DYN vs LSTA Comparison Chart in %
DYN
Daily Signal:
Gain/Loss:
LSTA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DYN vs. LSTA commentary
Nov 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Hold and LSTA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 28, 2025
Stock price -- (DYN: $21.17 vs. LSTA: $2.05)
Brand notoriety: DYN and LSTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 113% vs. LSTA: 43%
Market capitalization -- DYN: $3.03B vs. LSTA: $18.35M
DYN [@Biotechnology] is valued at $3.03B. LSTA’s [@Biotechnology] market capitalization is $18.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $109.65B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileLSTA’s FA Score has 1 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • LSTA’s FA Score: 1 green, 4 red.
According to our system of comparison, DYN is a better buy in the long-term than LSTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 3 TA indicator(s) are bullish while LSTA’s TA Score has 5 bullish TA indicator(s).

  • DYN’s TA Score: 3 bullish, 5 bearish.
  • LSTA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LSTA is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а +2.77% price change this week, while LSTA (@Biotechnology) price change was +0.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.22%. For the same industry, the average monthly price growth was +2.67%, and the average quarterly price growth was +74.99%.

Reported Earning Dates

DYN is expected to report earnings on Feb 26, 2026.

LSTA is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+8.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($3.03B) has a higher market cap than LSTA($18.3M). DYN YTD gains are higher at: -10.144 vs. LSTA (-31.208). LSTA has higher annual earnings (EBITDA): -20.83M vs. DYN (-437.37M). DYN has more cash in the bank: 684M vs. LSTA (22M). LSTA has less debt than DYN: LSTA (47K) vs DYN (121M). LSTA has higher revenues than DYN: LSTA (1.07M) vs DYN (0).
DYNLSTADYN / LSTA
Capitalization3.03B18.3M16,530%
EBITDA-437.37M-20.83M2,100%
Gain YTD-10.144-31.20833%
P/E RatioN/AN/A-
Revenue01.07M-
Total Cash684M22M3,109%
Total Debt121M47K257,447%
FUNDAMENTALS RATINGS
LSTA: Fundamental Ratings
LSTA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DYNLSTA
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signal:
Gain/Loss:
LSTA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMMGX10.760.08
+0.75%
Northern Multi-Manager Glbl Real Estate
PASRX21.950.15
+0.69%
Putnam Dynamic Asset Allocation Gr R
PDGIX87.270.53
+0.61%
T. Rowe Price Dividend Growth I
MCRFX15.270.08
+0.53%
BlackRock Mid-Cap Value Investor C
MSGRX13.30N/A
N/A
Meridian Small Cap Growth Institutional

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+1.78%
RNA - DYN
62%
Loosely correlated
+0.01%
IDYA - DYN
55%
Loosely correlated
+1.10%
SYRE - DYN
54%
Loosely correlated
+1.88%
XNCR - DYN
54%
Loosely correlated
+0.70%
CRNX - DYN
52%
Loosely correlated
+2.95%
More

LSTA and

Correlation & Price change

A.I.dvisor tells us that LSTA and RNA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSTA and RNA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSTA
1D Price
Change %
LSTA100%
-0.49%
RNA - LSTA
30%
Poorly correlated
+0.01%
RAIN - LSTA
29%
Poorly correlated
-4.22%
LGVN - LSTA
28%
Poorly correlated
+7.02%
CRIS - LSTA
28%
Poorly correlated
+10.62%
DYN - LSTA
27%
Poorly correlated
+1.78%
More